MarketsStocksVENMAX
VE

Venmax Drugs and Pharmaceuticals Ltd

NSE: VENMAXBSE: 531015Healthcare
22.87
+1.69%
NSE · 15-min delayed
Mkt Cap
₹28 Cr
P / E
139.0
P / B
2.0
ROE
1.4%
52W High
₹36.96
52W Low
₹19.01
Key Metrics
Market Cap
₹28 Cr
P / E
139.0
P / B
2.0
ROCE
1.6%
ROE
1.4%
Div Yield
-
Revenue · ₹ Cr
0
FY20
0
FY21
2
FY22
0
FY23
0
FY24
1
FY25
8
FY26
Net Profit · ₹ Cr
0
FY20
0
FY21
2
FY22
0
FY23
0
FY24
0
FY25
0
FY26
EPS · ₹ per share
₹-0.5
FY19
₹-0.5
FY20
₹-0.3
FY21
₹3.5
FY22
₹0.4
FY23
₹0.1
FY24
₹0.2
FY26
Q1 2026 snapshot
Sales
₹4 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.21
Scorecard · 7 axes
Quality
Weak
36/100
Valuation
Bad
139.0×
Growth
Avg
+7.1%
Profitability
Bad
1.5%
Performance
Bad
-5.4%
Entry Point
Good
62%
Red Flags
Strong
0 flags
Shareholding Pattern
13.8%Promoter
Promoter13.8%
Public86.2%
Quarterly Results · ₹ Cr
QuarterFY21 09QFY21 12QFY22 06QFY22 09QFY22 12QFY23 09Q
Revenue005,00,0005,00,0005,00,0000
Net Profit-3,42,000-3,41,0002,97,000-1,49,0001,81,200-0.028
NPM %--59.4%-29.8%36.2%-
AlertPre-trade